{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ICU.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ICU.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ICU.AU\",,,,,undefined,":{"symbol":"ICU.AU","market":"AU","secType":"STK","nameCN":"INVESTOR CENTRE LTD","latestPrice":0.002,"timestamp":1755497520000,"preClose":0.002,"halted":0,"volume":0,"delay":0,"nameEN":"INVESTOR CENTRE LTD","floatShares":114406918,"shares":304511335,"eps":-0.004552,"marketStatus":"Not Yet Opened","change":0,"latestTime":"08-18 16:12:00 AEST","open":0.002,"high":0.002,"low":0.002,"amount":0,"amplitude":0,"askPrice":0.003,"askSize":2416635,"bidPrice":0.002,"bidSize":66518,"shortable":3,"etf":0,"ttmEps":-0.004552,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1755561600000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.002,"openAndCloseTimeList":[[1755475200000,1755496800000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ICU.AU\",,,,,undefined,":{"symbol":"ICU.AU","floatShares":114406918,"roa":"-298.70%","roe":"-71.01%","lyrEps":-0.006359,"shares":304511335,"dividePrice":0,"high":0.002,"amplitude":0,"preClose":0.002,"low":0.002,"week52Low":0.001,"pbRate":"-0.20","psRate":"31.58","week52High":0.007,"institutionHeld":0,"latestPrice":0.002,"committee":-0.946425,"eps":-0.004552,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.004552,"open":0.002,"prevYearClose":0.002,"prevWeekClose":0.002,"prevMonthClose":0.002,"prevQuarterClose":0.002,"fiveDayClose":0.002,"twentyDayClose":0.002,"sixtyDayClose":0.003},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ICU.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ICU.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ICU.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2550572662","title":"Change of Director's Interest Notice-ICU.AX","url":"https://stock-news.laohu8.com/highlight/detail?id=2550572662","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550572662?lang=en_us&edition=fundamental","pubTime":"2025-07-09 08:31","pubTimestamp":1752021103,"startTime":"0","endTime":"0","summary":"https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250709:nASX7HzP0n","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250709:nASX4fqmn6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICU.AU","BK7054"],"gpt_icon":0},{"id":"2548810015","title":"SeaStar Medical Regains Nasdaq Compliance; Shares Rise After Hours","url":"https://stock-news.laohu8.com/highlight/detail?id=2548810015","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548810015?lang=en_us&edition=fundamental","pubTime":"2025-07-03 04:49","pubTimestamp":1751489348,"startTime":"0","endTime":"0","summary":"SeaStar Medical  said Wednesday it received confirmation from Nasdaq that it now meets the minimum $2.5 million stockholders' equity requirement and all other criteria for continued listing on the Nasdaq Capital Market.The company said the previously disclosed listing matter has been resolved and is now closed.Shares of SeaStar were up more than 11% in after-hours trading.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2210150020.SGD","LU2210149790.SGD","IE00BGHQF748.EUR","USJW.SI","IE00B64PRP62.GBP","BK4585","NDAQ","TSYW.SI","BK4588","BK7054","BK4112",".IXIC","PSQ","NVIW.SI","SQQQ","ICU.AU","QLD","USAW.SI","IE00BKPKM429.USD","NQmain","IE00B3QW5Z07.USD","LU2095319765.USD","ICU","TQQQ","MNQmain","BK4082","QID"],"gpt_icon":0},{"id":"2503583541","title":"SeaStar Medical Says FDA Approved Study on Selective Cytopheretic Device in Cardiorenal Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2503583541","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503583541?lang=en_us&edition=fundamental","pubTime":"2025-01-13 22:43","pubTimestamp":1736779396,"startTime":"0","endTime":"0","summary":"SeaStar Medical Holding  said Monday that the US Food and Drug Administration has approved its investigational device exemption application, allowing the conduct of a study to evaluate the safety and initial efficacy of its selective cytopheretic device, or SCD-Adult, in cardiorenal syndrome.The device will be evaluated in adults with acute heart failure and worsening renal function or severe right ventricular failure awaiting left ventricular assist device implantation, according to SeaStar Medical.The study is expected to include 20 patients at up to five clinical sites and is funded by a $3.6 million grant from the National Institutes of Health, SeaStar said.Shares of the company were 3% lower in early trading Monday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ICU.AU","BK4082","BK7054","ICU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}]}}